The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Chromosome Aberrations

This is a "connection" page, showing publications Olatoyosi Odenike has written about Chromosome Aberrations.
Connection Strength

0.319
  1. Myelodysplastic syndromes. Clin Lab Med. 2011 Dec; 31(4):763-84.
    View in: PubMed
    Score: 0.088
  2. The dawn of the molecular era of the myelodysplastic syndromes. N Engl J Med. 2011 Jun 30; 364(26):2545-6.
    View in: PubMed
    Score: 0.087
  3. Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia. Clin Cancer Res. 2008 Nov 01; 14(21):7095-101.
    View in: PubMed
    Score: 0.072
  4. An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS. Blood Adv. 2023 Jun 27; 7(12):2709-2714.
    View in: PubMed
    Score: 0.050
  5. High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML). Leuk Lymphoma. 2012 Mar; 53(3):445-50.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.